About CAPLYTA® (lumateperone)
8:48
About CAPLYTA® (lumateperone)
Dec 21, 2021
caplyta.com
🔍 Attention: FDA just approved Caplyta as adjunctive therapy for major depressive disorder. Let’s break down how this medication works and what side effects to look out for. * This video is for educational purposes only and is not a substitute for medical advice. Always talk to your doctor or pharmacist about your personal health needs. #pharmacist #mentalhealth #majordepressivedisorder #MDD #pharmacypractice #psychopharmacology #Caplyta #adjunctivetreatment #pharmacistsofinstagram #pharmacistt
1:17
🔍 Attention: FDA just approved Caplyta as adjunctive therapy for major depressive disorder. Let’s break down how this medication works and what side effects to look out for. * This video is for educational purposes only and is not a substitute for medical advice. Always talk to your doctor or pharmacist about your personal health needs. #pharmacist #mentalhealth #majordepressivedisorder #MDD #pharmacypractice #psychopharmacology #Caplyta #adjunctivetreatment #pharmacistsofinstagram #pharmacistt
17.8K views6 months ago
FacebookMillennialRx
Caplyta Explained #medication #mentalhealth #schizophrenia #bipolar #psychiatry
0:38
Caplyta Explained #medication #mentalhealth #schizophrenia #bipolar #psychiatry
3.1K viewsFeb 6, 2025
YouTubeMedical Centric Podcast
New clinical data highlights Caplyta® (lumateperone) as a promising option for achieving remission in adults with Major Depressive Disorder
New clinical data highlights Caplyta® (lumateperone) as a promising option for achieving remission in adults with Major Depressive Disorder
4 months ago
marketscreener.com
CAPLYTA (Lumateperone) FDA-Approved for MDD: What Clinicians Need to Know
CAPLYTA (Lumateperone) FDA-Approved for MDD: What Clinicians Need to Know
480 views5 months ago
vumedi.com
Lumateperone(Caplyta) Promising New Treatment For Bipolar Disorder and Schizophrenia | Mark Agresti
10:48
Lumateperone(Caplyta) Promising New Treatment For Bipolar Disorder and Schizophrenia | Mark Agresti
6.9K viewsMar 17, 2020
YouTubeDr. Mark Agresti - Integrative Psychiatrist
Caplyta (lumateperone) Uses, How It Works, and Common Side Effects
1:24
Caplyta (lumateperone) Uses, How It Works, and Common Side Effects
3.5K viewsMay 7, 2025
YouTubeDrugs.com
2:06
Caplyta (Lumateperone) a New Antipsychotic for Schizophrenia and Depressive Episodes in Bipolar
3.7K viewsJun 21, 2023
YouTubeAnthony Kelada MD
Johnson & Johnson: Supplemental new drug application submitted to U.S. FDA for CAPLYTA (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
10 months ago
finanznachrichten.de
CAPLYTA TV Spot, 'Let in the Lyte: Greater Relief'
2 months ago
iSpot.tv
1:05
💊 Medication Quiz Time: How much do you really know about Caplyta? 👀 Hint: All these questions were discussed in my Caplyta video posted this past week. #Pharmacist #MedicationQuiz #Caplyta #MentalHealthAwareness #PharmacyEducation | MillennialRx
3.4K views6 months ago
FacebookMillennialRx
0:48
Part 2: Caplyta = Dopamine Stabilizer Caplyta is classified as an atypical antipsychotic. I refer to this class as dopamine stabilizers due to their modulating effects. Caplyta is FDA-approved for schizophrenia and bipolar depression. Unipolar depression approval is coming soon. #Caplyta #DopamineStabilizer #AtypicalAntipsychotic #PsychNP #UnipolarDepression #BipolarDepression #SchizophreniaTreatment #MentalHealthMedication #FDAApprovalPending #Psychopharmacology #HolisticPsychiatry #Integrative
108 views10 months ago
FacebookAmbre Kerbee
8:01
Caplyta (Lumateperone): A Psychiatrist’s Honest Review | Weight, TD & Bipolar Use
1.5K views5 months ago
YouTubeDr. David Danish
CAPLYTA TV Spot, 'Real Progress'
Aug 11, 2020
iSpot.tv
9:44
Why Caplyta is the Game-Changing Medication for Mental Health: Exploring its Benefits
3.9K viewsSep 15, 2023
YouTubeInevid
0:15
Lumateperone (brand name Caplyta) is a new-generation atypical antipsychotic approved for schizophrenia and bipolar depression. It’s notable for its novel multimodal mechanism and favorable side-effect profile compared to older antipsychotics. | MRCP UK
1.6K views6 months ago
FacebookMRCP UK
7:36
🛑WHAT TO KNOW ABOUT CAPLYTA LUMATEPERONE 👉 Mental Health
3.5K viewsJul 13, 2021
YouTubeAliExpressDealsDaily
Dr. Ethan Melillo | Pharmacist on Instagram: "🔍 Attention: FDA just approved Caplyta as adjunctive therapy for major depressive disorder. Let’s break down how this medication works and what side effects to look out for. * This video is for educational purposes only and is not a substitute for medical advice. Always talk to your doctor or pharmacist about your personal health needs. #pharmacist #mentalhealth #majordepressivedisorder #MDD #pharmacypractice #psychopharmacology #Caplyta #adjunctive
93.8K views6 months ago
Instagrammillennialrx
1:19
Day 2 of tapering of my bipolar meds before switching to Caplyta. #caplyta #bipolardisorder #bipolarmeds #mentalhealth #bipolar
3.2K views2 months ago
TikTokmisha.banner
1:01
DRUG OF THE DAY: CAPLYTA #bipolar #schizophrenia #bipolardepression #pharmacist #pharmacy #shorts
8.9K viewsJan 27, 2024
YouTubeDr. Ethan Melillo, PharmD
3:00
Caplyta! My overall review and impressions of it. #psychiatry #pharmacology
3K viewsMay 16, 2025
YouTubeJoseph Elfar, MD | Psychiatrist
1:16
Impact of Caplyta FDA Approval, Notes from Roger McIntyre, MD, FRCPC
439 views6 months ago
YouTubePsychiatric Times
13:00
Caplyta 42 Mg : 1 year and 8 Months Review/Update about my life Atm.
992 viewsJun 24, 2024
YouTubeSam The Slam
22:58
Caplyta 42 Mg- One Month and 11 Days Update/ Talk About My LIfe.
2.7K viewsOct 18, 2022
YouTubeSam The Slam
5:16
CAPLYTA IMPORTANT SAFETY INFORMATION
58 views2 months ago
YouTubeCAPLYTA® (lumateperone)
1:13
CAPLYTA - THIS JUST IN!…FDA Approved New Indication Adjunct for MDD.
315 views6 months ago
YouTubeDr. Dree (PsychNP)
CAPLYTA TV Spot, 'Let in the Lyte: Moving on Without Me'
Mar 4, 2025
iSpot.tv
14:03
My Experience, Response, Review with Caplyta (Lumateperone), A New Atypical Antipsychotic
6.8K viewsOct 11, 2022
YouTubeBeyondBipolarBlog
10:37
New Phase 3 Data Behind the FDA Approval of Lumateperone (CAPLYTA) for Major Depressive Disorder
490 views5 months ago
YouTubeHCPLive
20:01
Caplyta (Lumateperone): EVERYTHING you NEED to Know!
16K viewsJul 14, 2024
YouTubeLevelheaded Mind
See more